Psoriasis Treatment Market Size & Share, by Drug Class (TNF Inhibitors, Interleukins Inhibitors); Type (Plaque Psoriasis, Psoriatic Arthritis); Route of Administration (Oral, Parenteral/systematic, Topical); Distribution Channel (Hospital, Retail Pharmacies, Online Pharmacies - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 4625
  • Published Date: Feb 14, 2023
  • Report Format: PDF, PPT

Companies Dominating the Psoriasis Treatment Landscape

    • LEO Pharma A/S
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Amgen Inc.
    • UCB S.A.
    • Merck & co. Inc.
    • Evelo Biosciences Inc.
    • Sun Pharmaceutical Industries ltd.
    • Johnson & Johnson Services Inc.
    • Navartis AG
    • AbbVie Inc.
    • Pfizer Inc.

Browse Key Market Insights with Data Illustration:


In The News

  • LEO Pharma – LEO Pharma receives positive CHMP opinion of adtralza for the treatment of adolescents with moderate-to-severe atopic dermatitis.

  • Amgen Inc. – Amgen announces positive top-line results from otzela phase 3 discreet study in moderate to severe genital psoriasis

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 4625
  • Published Date: Feb 14, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing prevalence of psoriasis and high demand for the treatment amid pandemic are the major factors driving the growth of the market.

The market is anticipated to attain a CAGR of ~8% over the forecast period, i.e., 2023 - 2033.

High cost of medication and fluctuation in disease condition are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are LEO Pharma A/S, Amgen Inc, UCB S.A., Merck & co., Evelo Biosciences Inc., Sun Pharmaceutical Industries ltd, Johnson & Johnson Services Inc., Navartis AG, AbbVie Inc., Pfizer Inc.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by Drug class, by type, by route of administration, by distribution channel, and by region.

The plaque psoriasis segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying